Dosing questions surround Novo Nordisk next-gen weight loss drug
CHICAGO — Novo Nordisk’s next-generation obesity injection targeting the amylin hormone showed substantial weight loss in an early study, but ...
Tag: Nordisk
Eli Lilly, Novo Nordisk, FDA, Makary, GSK
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your ...
Hims & Hers vs. Novo Nordisk: Are Compounded GLP-1s Safe?
Following Hims & Hers’ Super Bowl ad for its weight loss product, a debate has emerged over the safety of ...
Do We Need Humans in the Loop? A Novo Nordisk Exec Weighs In (Video)
Story follows beneath the quote from the extended video below “There’s very little need and this sounds cynical and I’m ...
Eli Lilly’s Zepbound Leads to Greater Weight Loss vs. Novo Nordisk Drug in Head-to-Head Test
The battle for market share between the two leaders in the booming obesity drug sector has a new data point ...
Novo Nordisk, Zepbound, Orexo, Arrakis
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your ...
Novo Nordisk GLP-1 Drug Meets Goals of MASH Trial, Setting Stage for FDA & EMA Filings
The blockbuster Novo Nordisk obesity drug Wegovy has met the main goals of a pivotal test in metabolic dysfunction steatohepatitis, ...
Discover the latest in health and fitness with Your Health 247. Get expert advice, workout routines, healthy recipes, and mental wellness tips to lead a healthier, happier life. Stay informed and empowered with us!